Effects of Propranolol on Neurodevelopmental Outcomes in Patients with Infantile Hemangioma: A Case-Control Study

Table 1

Demographic characteristics of the patient group and the healthy group.

Variable	Patient group	Control group	values
			0.663
Male	13 (36.1)	14 (41.2)
Female	23 (63.9)	20 (58.8)
Gestational
Term born (≥37 weeks)	30 (83.3)	29 (85.3)	0.822
Born prematurely (<37 weeks)	6 (16.7)	5 (14.7)
Age at neurodevelopment test (m)			0.478

are presented as the number (percentage). Values are presented as the mean ± standard deviation.